Maine Seeks Public Comment on Drug Affordability
Residents have until November 30 to submit input on financial barriers to prescription medications.
Updated on Nov. 19, 2026 in Politics

Live Poll
Have prescription drug costs made it harder for you to afford your medications this year?
The Maine Office of Affordable Health Care is accepting public comments on financial and other barriers to accessing prescription medications through 5 p.m. Monday, November 30. Comments will be shared with the Prescription Drug Affordability Board, which is developing recommendations for lawmakers.
Why it matters
A 2026 survey released by Consumers for Affordable Health Care found more than four in ten Maine households incurred medical debt in the previous two years, and 51% of those households cited prescription drug costs. Roughly one in three Mainers reported trying to self-medicate or find alternatives to recommended treatment because of cost.
The survey gives a state-level picture of medication cost burdens, though the extraction does not detail its sample size or methodology. Policy options under review, including strategies to reduce patient out-of-pocket costs, have not yet been determined.
The players
Maine Office of Affordable Health Care
A state office that accepts public input on barriers to prescription medication access and forwards comments to the Prescription Drug Affordability Board.
Maine Prescription Drug Affordability Board
A state board created in 2019 that examines drug pricing and affordability and advises the Legislature on policy options to lower prescription costs.
The details
Residents can submit comments by emailing a designated address before the deadline. The Prescription Drug Affordability Board, established in 2019, had its responsibilities expanded by legislation enacted in 2026 and must examine policy options, including strategies to reduce patient out-of-pocket costs.
Timeline
2019: The Prescription Drug Affordability Board was established.
2026: Legislation expanded the board's responsibilities, and the Consumers for Affordable Health Care survey was released.
November 30, 2026: Public comment deadline at 5 p.m. Monday.
October 2027: The board must deliver detailed recommendations to the Legislature.
Political Context
Advocate Woloson hopes lawmakers will consider using Medicare-negotiated drug prices as a reference for state programs. Lawmakers are also weighing limits on what publicly funded health programs pay for certain expensive medications.
Mainers who want to weigh in on medication costs can email their comments before 5 p.m. Monday, November 30. The board's eventual recommendations could shape what residents pay out of pocket for prescriptions.
The takeaway
Medication costs are a shared burden for Maine households, and public input during this comment period will inform the board's recommendations to lawmakers. Residents who have faced cost barriers can submit their experiences before the deadline.
What happens next
The Prescription Drug Affordability Board must deliver detailed recommendations to the Legislature by October 2027.
Further reading
For related coverage of how state agencies handle health policy, browse Government reporting on Maine.
Source note: This article includes information reported by Maine Beacon - A project of the Maine People's Alliance.
Live Poll
Have prescription drug costs made it harder for you to afford your medications this year?






